Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Schmid, Chen-Hsuan Ho, F. Chrétien, Juliette Lefebvre, G. Pivert, M. Kosco-Vilbois, W. Ferlin, F. Geissmann, A. Fischer, G. Basile (2009)
Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient miceEMBO Molecular Medicine, 1
M. Jordan, David Hildeman, J. Kappler, P. Marrack (2004)
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.Blood, 104 3
R. Marsh, K. Rao, P. Satwani, K. Lehmberg, I. Müller, Dandan Li, Mi‐Ok Kim, A. Fischer, S. Latour, P. Sedláček, V. Barlogis, K. Hamamoto, H. Kanegane, Samuel Milanovich, D. Margolis, D. Dimmock, J. Casper, Dorothea Douglas, P. Amrolia, P. Veys, Ashish Kumar, M. Jordan, J. Bleesing, A. Filipovich (2013)
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.Blood, 121 6
S. Chaleff, M. Otto, R. Barfield, T. Leimig, R. Iyengar, J. Martín, M. Holiday, J. Houston, T. Geiger, V. Huppert, R. Handgretinger (2007)
A large-scale method for the selective depletion of αβ T lymphocytes from PBSC for allogeneic transplantationCytotherapy, 9
K. Lehmberg, M. Albert, R. Beier, K. Beutel, B. Gruhn, N. Kröger, R. Meisel, A. Schulz, D. Stachel, W. Woessmann, G. Janka, I. Müller (2014)
Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosisHaematologica, 99
R. Marsh, G. Vaughn, Mi‐Ok Kim, Dandan Li, S. Jodele, S. Joshi, P. Mehta, S. Davies, M. Jordan, J. Bleesing, A. Filipovich (2010)
Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.Blood, 116 26
Franco Prof, C. Allen, F. Benedetti, A. Grom, M. Ballabio, W. Ferlin, C. Min (2015)
A Novel Targeted Approach to the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody (mAb), NI-0501: First Results from a Pilot Phase 2 Study in Children with Primary HLHBlood, 126
J Clin Immunol (2017) 37:511–513 DOI 10.1007/s10875-017-0413-7 LETTER TO EDITOR IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH 1 1 1 Ciara O’Rafferty & Mark Velangi & Sarah Lawson & 1 1 Prashant Hiwarkar & Jayashree Motwani Received: 17 April 2017 /Accepted: 14 June 2017 /Published online: 21 June 2017 Springer Science+Business Media, LLC 2017 The outcomes of hematopoietic stem cell transplantation The patient was commenced on the HLH 2004 protocol on (HSCT) for refractory hemophagocytic lymphohistiocytosis day ten of life (twice weekly etoposide, dexamethasone and (HLH) in X-linked inhibitor of apoptosis protein (XIAP) de- cyclosporin). Inflammatory markers showed a slow partial ficiency are poor [1]. Amongst other functions, XIAP regu- response to initial therapy but on steroid taper, fevers re- emerged and ferritin rapidly increased. HLH 2004 protocol lates apoptosis in hepatocytes and other cells and its deficien- cy may result in increased sensitivity to chemotherapy. A high was complicated by Staphylococcus epidermidis bacteremia, rate of transplant-related mortality (TRM) is observed follow- Enterococcus growth from urine and respiratory syncytial vi- ing both myeloablative and reduced-intensity conditioning rus infection all of which responded promptly to antimicrobial regimens. Treatment-related mortality is attributed to uncon- treatment.
Journal of Clinical Immunology – Springer Journals
Published: Jun 21, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.